ClinConnect ClinConnect Logo
Search / Trial NCT06673953

Effect of Respiratory Trainer on Cardiopulmonary Functions in Patients with Upper Cross Syndrome Post-Cardiac Surgery

Launched by CAIRO UNIVERSITY · Nov 2, 2024

Trial Information

Current as of November 09, 2025

Recruiting

Keywords

Post Cabg / Upper Cross Syndrome / Respiratory Muscle Training

ClinConnect Summary

This clinical trial is looking at how respiratory training can help improve lung and heart functions in men who have had heart surgery, specifically those with a condition called Upper Cross Syndrome. This syndrome often results from poor posture and can lead to neck pain and weakened breathing muscles. The study will involve 60 male patients, aged between 45 and 55 years, who have undergone a type of heart surgery called coronary artery bypass grafting (CABG) at least three months prior to joining the trial. To be eligible, participants should have a specific neck posture and experience mild to moderate neck pain, along with lower than normal lung function measurements.

Participants in this study will engage in respiratory training exercises aimed at strengthening their breathing muscles. Throughout the trial, they can expect to undergo assessments to monitor their progress in lung and heart function. It’s important to note that individuals with certain health issues, like severe neck problems, significant respiratory diseases, or those who smoke, will not be able to participate. This study aims to find out if this training can make a difference in their recovery and overall health after heart surgery.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old.
  • Craniovertebral angle \< 51°, but not less than 30°.
  • Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to upper limbs.
  • VAS score between 3-7.
  • Their body mass index ranges from (25 -29.9) kg/m2.
  • Values of FEV1 and FVC lower than 80%
  • Exclusion Criteria:
  • Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain.
  • History of respiratory disease and clinical signs of severe cardiac events.
  • Neurological disorders which affect the diaphragm.
  • Patients whose BMI is less than 25, or greater than 30 kg/m2.
  • Smokers.
  • Values of FEV1 and FVC higher than 80%
  • Patients with chronic obstructive pulmonary disease or asthma.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Giza, Egypt

Patients applied

0 patients applied

Trial Officials

Zeinab Helmy, Professor

Study Chair

Professor of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University

El-Sayed Felaya, Lecturer

Study Director

Lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University

Ahmed Elsisi, Assistant Professor

Study Director

Assistant Professor of Critical Care Medicine. Faculty of Medicine. Beni suef University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported